COMMUNIQUÉS West-GlobeNewswire

Celldex Presents Promising Data from CDX-527 Bispecific and TAM Receptor Programs at American Association for Cancer Research (AACR) Annual Meeting 2019
01/04/2019
HAMPTON, N.J., April 01, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) presented promising data from the Company’s growing bispecific and TAM (Tyro3, Axl, MerTK) receptor programs during poster [...]
Apollomics, Inc. Presents Positive Preclinical Data on APL-102, an oral Multi-Kinase Inhibitor with CSF-1R Activity
01/04/2019
Activity Demonstrated as a Single Agent and in Combination with an anti-PD-1 antibody FOSTER CITY, Calif. and HANGZHOU, China, April 01, 2019 (GLOBE NEWSWIRE) -- Apollomics, Inc. (the “Company”), an innovative [...]
Constellation Pharmaceuticals Presents Results from Phase 1b Portion of ProSTAR Clinical Trial of CPI-1205 at AACR Meeting
01/04/2019
Clinical activity of CPI-1205 was seen in subsets of advanced metastatic castration-resistant prostate cancer (mCRPC) patients Recently initiated Phase 2 portion of ProSTAR includes randomized testing of CPI-1205 in [...]
Athersys to Participate in Two Upcoming Healthcare Conferences
01/04/2019
CLEVELAND, April 01, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today the Company’s participation in two upcoming biotechnology and healthcare conferences. On April 4 th , Athersys will be part of [...]
American College of Rheumatology Targets Step Therapy and Drug Pricing in New Position Statements
01/04/2019
ATLANTA, April 01, 2019 (GLOBE NEWSWIRE) -- American College of Rheumatology Targets Step Therapy and Drug Pricing in New Position Statements ATLANTA – The American College of Rheumatology (ACR) has released new drug [...]
MicroPulse TSCPC featured in multiple abstracts, posters, presentations and wet lab at the World Glaucoma Congress
01/04/2019
MOUNTAIN VIEW, Calif., April 01, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced [...]
Catalyst Biosciences Receives Orphan Designation from the European Commission for Marzeptacog Alfa (Activated)
01/04/2019
Dosing successfully completed in the Phase 2 portion of the Phase 2/3 MarzAA trial for the treatment of hemophilia A or B with inhibitors SOUTH SAN FRANCISCO, Calif., April 01, 2019 (GLOBE NEWSWIRE) -- Catalyst [...]
Ossur Hf : Transactions in relation to share buyback program
01/04/2019
Announcement no. 22/2019 1 April 2019 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
CardieX Group Company inHealth CEO & Co-Founder Aubrey Jenkins Secures Position on Prestigious MM&M Top 40 Healthcare Transformers Honor Roll
01/04/2019
Highlights CardieX group Company inHealth Medical Services CEO & Co-Founder Aubrey Jenkins awarded place on MM&M’s 2019 class of Top 40 Healthcare Transformers Honor Roll recognises visionaries, self-starters [...]
Information relative au nombre total de droits de vote et d’actions composant le capital social au 31 mars 2019
01/04/2019
Paris, le 1 er avril 2019 – 18 :00 CET - Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue, de vivre de [...]
Information on total number of voting rights and shares composing the share capital as at March 31st, 2019
01/04/2019
Paris, April 1 st , 2019 – 6.00PM CET - Pixium Vision (FR0011950641 - PIX), a bioelectronic company developing innovative bionic vision systems to allow patients who have lost their sight to lead more independent lives [...]
Taconic Biosciences Licenses the Wild Mouse Gut Microbiome from the National Institute of Diabetes and Digestive and Kidney Diseases
01/04/2019
RENSSELAER, N.Y., April 01, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces it has obtained a license to the Wild Mouse gut microbiome [...]
Resverlogix Cognition Substudy of the BETonMACE Phase 3 Cardiovascular Trial Presented at the International Conference on Alzheimer’s & Parkinson’s Diseases
01/04/2019
CALGARY, Alberta, April 01, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) today announces that Dr. Jeffrey Cummings, Founding Director of the Cleveland Clinic Lou Ruvo Brain [...]
Share buy-back week 13/2019
01/04/2019
Announcement 1 April 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling up [...]
I-MED Pharma Celebrates 30 Years of Providing OSD & Surgical Solutions to the Global Eye Care Community
01/04/2019
MONTREAL, April 01, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, proudly announces its 30-year anniversary providing OSD & Surgical solutions to [...]
Olainfarm: The Decision Of Individual Shareholders On Changes In The JSC Olainfarm Council Is Illegal
01/04/2019
The Board of JSC Olainfarm confirms, that previously cancelled extraordinary meeting of shareholders planned for April 1, did not take place today. JSC Olainfarm's Management Board assesses the actions taken by [...]
Acasti Pharma Announces Publication of CaPre Bioavailability Study in Leading Peer-Reviewed Journal
01/04/2019
Further validates prior study results demonstrating that the bioavailability of CaPre is significantly better than LOVAZA when taken with a low-fat meal LAVAL, Québec, April 01, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma [...]
Yield Growth Builds Impressive Distribution Network -- CFN Media
01/04/2019
SEATTLE, April 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an [...]
Spine Injury Solutions Announces Results for Fiscal Year 2018
01/04/2019
HOUSTON, April 01, 2019 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB: SPIN) today announced financial results for its fiscal 2018 year ended December 31, 2018. Dr. William Donovan, Chairman and Chief [...]

Pages